Skip to main content
Erschienen in: European Journal of Medical Research 9/2011

01.12.2011 | Case report

Successful Non-Invasive treatment of stricturing fibrosing colonopathy in an adult patient

verfasst von: G Terheggen, D Dieninghoff, E Rietschel, U Drebber, W Kruis, L Leifeld

Erschienen in: European Journal of Medical Research | Ausgabe 9/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

Fibrosing colonopathy (FC) is a rare entity associated with cystic fibrosis (CF). Until now, patients with stricturing FC have usually been treated surgically. In this instance, we aimed at avoiding surgery by applying a new conservative approach.

Methods

Case report on an adult with CF who developed persistent abdominal pain due to a non-passable stricture in the right transverse colon. Histology confirmed fibrosing colonopathy.

Results

Initially we treated the patient with prednisolone pulse therapy and additive antibiotic therapy. For maintenance therapy we administered budesonide. The patient underwent clinical, laboratory and endoscopic follow-up over a three-year period. The stricture healed and was easy to pass. A relapse in the cecum at the ileocecal valve again improved under steroid and antibiotic therapy.

Conclusions

We present a novel therapeutic approach for advanced stricturing FC in an adult patient which successfully avoided surgery (right hemicolectomy) over a three year follow up.
Literatur
1.
Zurück zum Zitat The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis N Engl J Med 1993, 329: 1308–13. The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis N Engl J Med 1993, 329: 1308–13.
2.
Zurück zum Zitat FitzSimmons SC, Burkhart GA, Borowitz D, et al.: Highdose pancreatic enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997, 336: 1283–9. 10.1056/NEJM199705013361803PubMedCrossRef FitzSimmons SC, Burkhart GA, Borowitz D, et al.: Highdose pancreatic enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997, 336: 1283–9. 10.1056/NEJM199705013361803PubMedCrossRef
3.
Zurück zum Zitat Häusler M, Meilicke R, Biesterfeld S, Heimann G: First adult patient with fibrosing colonopathy. Am J Gastroenterol 1998, 93: 1171–2.PubMedCrossRef Häusler M, Meilicke R, Biesterfeld S, Heimann G: First adult patient with fibrosing colonopathy. Am J Gastroenterol 1998, 93: 1171–2.PubMedCrossRef
4.
Zurück zum Zitat Mack EH, Brett AS, Brown D: Fibrosing colonopathy in an adult cystic fibrosis patient after discontinuing pancreatic enzyme therapy. South Med J 2004, 97: 901–4. 10.1097/01.SMJ.0000129939.14179.FEPubMedCrossRef Mack EH, Brett AS, Brown D: Fibrosing colonopathy in an adult cystic fibrosis patient after discontinuing pancreatic enzyme therapy. South Med J 2004, 97: 901–4. 10.1097/01.SMJ.0000129939.14179.FEPubMedCrossRef
5.
Zurück zum Zitat Franzen D, Went P, Buhlmann U: Fibrosing colonopathy in absence of pancreatic enzyme supplementation in one adult patient with cystic fibrosis. Indian J Gastroenterol 2008, 27: 133–4.PubMed Franzen D, Went P, Buhlmann U: Fibrosing colonopathy in absence of pancreatic enzyme supplementation in one adult patient with cystic fibrosis. Indian J Gastroenterol 2008, 27: 133–4.PubMed
6.
Zurück zum Zitat Bansi DS, Price A, Russell C, Sarner M: Fibrosing colonopathy in an adult owing to over use of pancreatic enzyme supplements. Gut 2000, 46: 283–5. 10.1136/gut.46.2.283PubMedCentralPubMedCrossRef Bansi DS, Price A, Russell C, Sarner M: Fibrosing colonopathy in an adult owing to over use of pancreatic enzyme supplements. Gut 2000, 46: 283–5. 10.1136/gut.46.2.283PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Gaia E, Sambatoro A, De Giuli P, Angeli A: Adult fibrosing colonopathy associated with mesalazine treatment. Am J Gastroenterol 2001, 96: 2508–9.PubMedCrossRef Gaia E, Sambatoro A, De Giuli P, Angeli A: Adult fibrosing colonopathy associated with mesalazine treatment. Am J Gastroenterol 2001, 96: 2508–9.PubMedCrossRef
8.
Zurück zum Zitat Haber HP, Benda N, Fitzke G, et al.: Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls. Gut 1997, 40: 406–11.PubMedCentralPubMedCrossRef Haber HP, Benda N, Fitzke G, et al.: Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls. Gut 1997, 40: 406–11.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Dialer I, Hundt C, Bertele-Harms RM, Harms HK: Sonographic evaluation of bowel wall thickness in patients with cystic fibrosis. J Clin Gastroenterol 2003, 37: 55–60. 10.1097/00004836-200307000-00014PubMedCrossRef Dialer I, Hundt C, Bertele-Harms RM, Harms HK: Sonographic evaluation of bowel wall thickness in patients with cystic fibrosis. J Clin Gastroenterol 2003, 37: 55–60. 10.1097/00004836-200307000-00014PubMedCrossRef
10.
Zurück zum Zitat Reichard KW, Vinocur CD, Franco M, et al.: Fibrosing colonopathy in children with cystic fibrosis. J Pediatr Surg 1997, 32: 237–41. 10.1016/S0022-3468(97)90186-XPubMedCrossRef Reichard KW, Vinocur CD, Franco M, et al.: Fibrosing colonopathy in children with cystic fibrosis. J Pediatr Surg 1997, 32: 237–41. 10.1016/S0022-3468(97)90186-XPubMedCrossRef
11.
Zurück zum Zitat Schwarzenberg SJ, Wielinski CL, Shamieh I, et al.: Cystic fibrosis-associated colitis and fibrosing colonopathy. J Pediatr 1995, 127: 565–70. 10.1016/S0022-3476(95)70113-3PubMedCrossRef Schwarzenberg SJ, Wielinski CL, Shamieh I, et al.: Cystic fibrosis-associated colitis and fibrosing colonopathy. J Pediatr 1995, 127: 565–70. 10.1016/S0022-3476(95)70113-3PubMedCrossRef
12.
Zurück zum Zitat Dodge JA: The aetiology of fibrosing colonopathy. Postgrad Med J 1996,72(suppl 2):S52–5.PubMed Dodge JA: The aetiology of fibrosing colonopathy. Postgrad Med J 1996,72(suppl 2):S52–5.PubMed
13.
Zurück zum Zitat Lloyd-Still JD, Beno DW, Kimura RM: Cystic fibrosis colonopathy. Curr Gastroenterol Rep 1999, 1: 231–7. 10.1007/s11894-999-0040-4PubMedCrossRef Lloyd-Still JD, Beno DW, Kimura RM: Cystic fibrosis colonopathy. Curr Gastroenterol Rep 1999, 1: 231–7. 10.1007/s11894-999-0040-4PubMedCrossRef
14.
Zurück zum Zitat Lloyd-Still JD: Cystic fibrosis and colonic strictures. A new "iatrogenic" disease. J Clin Gastroenterol 1995, 21: 2–5. 10.1097/00004836-199507000-00001PubMedCrossRef Lloyd-Still JD: Cystic fibrosis and colonic strictures. A new "iatrogenic" disease. J Clin Gastroenterol 1995, 21: 2–5. 10.1097/00004836-199507000-00001PubMedCrossRef
15.
Zurück zum Zitat Stevens JC, Maguiness KM, Hollingsworth J, et al.: Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy. J Pediatr Gastroenterol Nutr 1998, 26: 80–4. 10.1097/00005176-199801000-00014PubMedCrossRef Stevens JC, Maguiness KM, Hollingsworth J, et al.: Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy. J Pediatr Gastroenterol Nutr 1998, 26: 80–4. 10.1097/00005176-199801000-00014PubMedCrossRef
Metadaten
Titel
Successful Non-Invasive treatment of stricturing fibrosing colonopathy in an adult patient
verfasst von
G Terheggen
D Dieninghoff
E Rietschel
U Drebber
W Kruis
L Leifeld
Publikationsdatum
01.12.2011
Verlag
BioMed Central
Erschienen in
European Journal of Medical Research / Ausgabe 9/2011
Elektronische ISSN: 2047-783X
DOI
https://doi.org/10.1186/2047-783X-16-9-411

Weitere Artikel der Ausgabe 9/2011

European Journal of Medical Research 9/2011 Zur Ausgabe